Decryption β A single injection was sufficient for remission in ten patients with hereditary angioedema.
A new rare but potentially fatal genetic disease, hereditary angioedema, has been cured by gene therapy. And for transthyretin amyloidosis in 2021, a single injection of treatment using the Crispr-Cas9 genetic scissors technique was enough to free patients from lifelong treatment. This is a pilot study conducted on 10 patients and published in the journal New England Journal of Medicine
Who has just announced it.Hereditary angioedema manifests itself as a sudden, irregular and sometimes painful swelling of certain tissues, especially in the skin and digestive tract. Attacks, which usually begin in childhood, are transient but can lead to death by suffocation if they affect the upper airways. In France, 1,500 people are affected by the disease, of which 800 are already being monitored by the National Reference Center for Angioedema (Criac). isβ
(TagsToTranslate)Rare Diseases
This is a new record that scientists from the Korea Fusion Energy Institute (KFE) have…
Damages associated with drought, floods, hail and other increasingly violent events are expected to increase…
An estimated 9 million people in the United States are still waiting for their final…
The death of seven humanitarian workers from the American NGO World Central Kitchen in an…
Today, at one o'clock in the morning, Gamer updates it Boutique de Fortnite Through the…
The Basic Instinct and Casino actress looks back at a time in Hollywood when adapting…